HLA-C*04 antigen

increased frequency in type 2 diabetes

Also Known As:

HLA Cw4; HLA-Cw4

Networked: 22 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*04 antigen: 22
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*04 antigen: 22
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*04 antigen: 22
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-C Antigens: 714
        HLA-C*04 antigen: 22
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*04 antigen: 22
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-C Antigens: 714
        HLA-C*04 antigen: 22
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*04 antigen: 22

Experts

1.	Blyth, Christopher C: 1 article (08/2014)
2.	Dunn, David: 1 article (08/2014)
3.	Keane, Niamh M: 1 article (08/2014)
4.	Lucas, Andrew: 1 article (08/2014)
5.	Lucas, Michaela: 1 article (08/2014)
6.	Mallal, Simon: 1 article (08/2014)
7.	McKinnon, Elizabeth: 1 article (08/2014)
8.	Pavlos, Rebecca K: 1 article (08/2014)
9.	Phillips, Elizabeth: 1 article (08/2014)
10.	Rive, Craig: 1 article (08/2014)

Related Diseases

1.	Coronary Disease (Coronary Heart Disease) 10/01/1984 - "The findings helped to draw a conclusion as to the presence of associative links between a number of the studied antigens (A (II), MN, HLA-B7, HLA-B14, HLA-B15, HLA-CW4) and the risk of the development of, at least, some forms of coronary heart disease."
2.	Type 2 Diabetes Mellitus (MODY) 12/01/1983 - "Increased frequency of HLA-Cw4 in type 2 diabetes." 01/01/1992 - "Analysis of the HLA loci A, B, C, DR and DQ (35 determinations) in 35 hyperthyroid patients with NIDDM and in 386 subjects from the general population revealed a highly significant difference between them in the incidence of HLA-Cw4, -DR2, -DQw1, -DQw3 and -DQw4. " 11/01/1986 - "Age at onset and body mass index were unrelated to HLA antigens, but the Type 2 diabetic patients with HLA-Cw4, DR5 and DR6 showed a strong family history for Type 2 diabetes. "
3.	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/01/2004 - "[Commentaries on the article "HLA CW3 and HLA CW4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients"]." 07/01/2003 - "HLA CW3 and HLA CW4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients."
4.	Infections 01/01/2005 - "HLA-Cw4 specificity acts as protector in development of chronic HCV-infection. " 05/01/1999 - "Also, HLA-Cw4 was significantly associated with HSV-2 infection. "
5.	Venous Thromboembolism 05/01/1982 - "[Venous thromboembolism susceptibility associated with HLA-Cw4]."

Related Drugs and Biologics

1.	Antigens
2.	HLA-B15 Antigen
3.	HLA-B14 Antigen
4.	HLA-C*03 antigen
5.	HLA-DRB1 Chains (HLA DRB1)
6.	Complementary DNA (cDNA)
7.	HLA-DR4 Antigen (HLA DR4 Antigen)
8.	HLA-B35 Antigen (HLA B35 Antigen)
9.	HLA-B8 Antigen (HLA B8 Antigen)
10.	Histocompatibility Antigens Class I

Related Therapies and Procedures

1.	Immunotherapy